Company Snapshot Home > Equity > Corporate Information > Company Snapshot
|
|
| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
203.75
|
|
Change (%)
|
9.90 (5.11%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
191.00
-
207.90
|
|
52-Week Range (RS)
|
163.70
-
348.10
|
|
Beta (1 Year)
|
0.89
|
|
|
|
|
|
| Index Details |
| BSE HC, BSE SmallCap |
| News |
|
Corporate Details |
| Indoco Remedies receives EU GMP certification from Malta Medicines Authority |
| Board of Indoco Remedies recommends Final Dividend |
| Indoco Remedies reports consolidated net loss of Rs 21.64 crore in the March 2026 quarter |
| Indoco Remedies gains after reporting turnaround Q4 performance |
| Indoco Remedies to announce Quarterly Result & final dividend |
| Indoco Remedies rises on USFDA approval for Brivaracetam oral solution |
| Indoco Remedies allots 55,700 equity shares under ESOP |
| Indoco Remedies reports consolidated net loss of Rs 29.79 crore in the December 2025 quarter |
| Indoco Remedies receives USFDA approval for Lacosamide Oral Solution |
| Indoco Remedies schedules board meeting |
|
|
|
| Incoporation Year : 1947 |
| Chairman : Suresh G Kare |
| Ownership Group : Indian Private |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Registered Office |
Indoco Remedies Ltd
Indoco House 166 C S T Road,
Santacruz (East) Kalina,
Mumbai,
Maharashtra-400098 |
Phone:91-022-26541851-55
Fax:91-022-26520787 |
| E-Mail : compliance.officer@indoco.com |
| URL : http://www.indoco.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
20-May-2026 |
211.30 |
-3.57 |
| 1Month |
27-Apr-2026 |
210.00 |
-2.98 |
| 3Month |
27-Feb-2026 |
202.40 |
0.67 |
| 6Month |
27-Nov-2025 |
257.85 |
-20.98 |
| 1Year |
27-May-2025 |
248.60 |
-18.04 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| Quant Small Cap Fund |
0.29 |
87.97 |
| DSP Healthcare Fund |
2.16 |
67.74 |
| Nippon India Small Cap Fund |
0.07 |
54.35 |
| Franklin India Small Cap Fund |
0.31 |
42.43 |
| Nippon India Pharma Fund |
0.46 |
38.44 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Sun Pharmaceutical Industries Ltd |
1,845.00 |
0.24 |
1,917.15 |
1,547.25 |
442,677.30 |
| Cipla Ltd |
1,418.20 |
0.08 |
1,672.20 |
1,165.55 |
114,562.27 |
| Dr Reddys Laboratories Ltd |
1,319.05 |
-0.77 |
1,377.95 |
1,149.00 |
110,095.43 |
| Zydus Lifesciences Ltd |
1,085.95 |
0.65 |
1,093.95 |
835.85 |
109,271.98 |
| Lupin Ltd |
2,276.75 |
0.57 |
2,492.00 |
1,838.65 |
104,096.62 |
|
|
|
|